Skip to main content

Drug Safety

      Risk of poor pregnancy outcomes in lupus patients continues to remain high, especially in the setting of high disease activity. Significant racial and ethnic disparities are also described in this…
      JAK/TYK Inhibitors in SLE
      APIPPRA Study in Preclinical RA
      An update on JAK inhibitors and cardiovascular risks

      Dr. Antoni Chan ( @synovialjoints ) shares #EULAR23 developments
      1 year 5 months ago
      An update on JAK inhibitors and cardiovascular risks Dr. Antoni Chan ( @synovialjoints ) shares #EULAR23 developments on JAK/TYK2 inhibitors. https://t.co/yZqHEg73bn https://t.co/CzVH62LEgL
      Tune it at 1pm EST for RheumNow's daily #EULAR23 recaps. You can find us live on Twitter, YouTube and LinkedIn. https:/
      1 year 5 months ago
      Tune it at 1pm EST for RheumNow's daily #EULAR23 recaps. You can find us live on Twitter, YouTube and LinkedIn. https://t.co/t531csjXo8
      RT @gurdeep_dulay: ✅Benefit of adding #HydroxyChloroquine #HCQ in refractory obstetric #APS

      #EULAR2023 poster https
      1 year 5 months ago
      ✅Benefit of adding #HydroxyChloroquine #HCQ in refractory obstetric #APS #EULAR2023 poster https://t.co/dgGY496dbh
      RT @synovialjoints: Factors related to having a flare of arthritis during COVID-19 include female gender, higher disease
      1 year 5 months ago
      Factors related to having a flare of arthritis during COVID-19 include female gender, higher disease activity, no DMARD at time of vaccination. Stopping DMARDs need to be weighed up against risk of flares, Pedro Machado, COVID-19 #EULAR2023 @RheumNow https://t.co/3sd32tF2kW